Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy

Mise à jour : Il y a 4 ans
Référence : NCT00251680

Femme et Homme

Extrait

The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with established lipid-lowering therapy in subjects with type 2 diabetes mellitus.


Critère d'inclusion

  • Type 2 Diabetes


Liens